Bioprocess Pharmaceutical Filtration

How to Successfully Scale-Up Automated Single-Use Bioprocesses

Speed to market is critical for biomanufacturers. The faster a process can be scaled-up, the faster a return on investment on drug development costs can be realized. With a strong trend towards the use of single-use technologies (SUT) in bioprocessing, what strategies can be implemented during research and development (R & D) to ensure successful scale-up to commercial manufacturing?

Thinking ahead

When developing new drugs, biotech companies need to focus on the end goal, which is ultimately a validated, approved commercial manufacturing process. Ideally the supply chain is locked down and the procedures are in place to repeatedly produce a product safely.

In a stainless steel processing facility it may be difficult or impossible to make more material with the same equipment when market success leads to the need for additional capacity or facility throughput. A new facility may need to be built just to accommodate the additional demand, which could lead to shortages.

Mobile, single-use and completely contained processing units or systems with closed flowpaths, on the other hand, take up less permanent space and can be set up very quickly.

Facilitating scale-up

So what mind set must be adopted to make the transition from one to the other as seamless as possible? 

First of all, biotech companies shouldn't wait to adopt single-use automated technology at the pilot level as scale-up issues may arise at the R & D stage. In addition, they should make sure that the materials used in R & D are the same technology that can be used aseptically with automated technology at pilot and process scales. 

Find out more about successfully scaling-up single-use bioprocesses in the Scale-Up section of our Bioprocessing Knowledge and Resource Hub.

Consistent strategies

Successful scale-up can be ensured by utilizing the same automated single-use equipment and strategies in R & D through to manufacturing scale and relying on the expertise of scale-up specialists. Using this strategy, a significant reduction of rework and inefficiencies can be expected in processes that would otherwise be extremely difficult to change once approved.

How to Succesfully Scale Up Automated single Use Bioprocesses_ Infographic_Bridge-the-gap

 

 

 

Click on the infographic for a summary of the benefits of using a consistent approach to automated SUT at R & D and manufacturing scales.

 

 

 

 

 

What do you think? What challenges does your company face when scaling-up automated single-use bioprocesses? Share your experience and insight in the comments section below. 

 

We will exhibit at BioTech 2016 Conference, September 5&6 in Wädenswil-ZH, Switzerland. Discover Parker's range of single-use TFF systems which improve filter performance and reduce purification costs all while achieving walk-away automate of your TFF process: SciLog® Single-Use TFF Systems.

 

This post was contributed by Donald Beers, Engineering Supervisor (Single-Use Technology) at Parker domnick hunter Process Filtration, USA

 

At Parker domnick hunter, we specialize in automating and controlling single-use processes. By integrating sensor and automation technology into a process, a manufacturer can control the fluid flow more effectively, ensuring the quality of the final product from process development to GMP manufacturing

 

For additional information, please contact Parker domnick hunter Process Filtration: 877 784 2234 (North America Toll Free) +1 805 604 3400 (North America) +44 (0)191 410 5121 242 (Rest of World), dhpinfo@parker.com, www.parker.com/dhsingleuse

 

Related blog posts

5 Benefits of Single-Use Technology vs Stainless Steel

10 Things to Consider When Assessing Your Single-Use Bioprocess Automation Requirements

Automation of Final Bulk Filtration and Container Fill Step in GMP Environment

A Strategy for Avoiding Manual Errors in Biomanufacturing

Understanding and Controlling Bioprocess Variation

7 Tips for Successful QbD Implementation in Biomanufacturing

Categories
Recent Posts by Author

The Biopharmaceutical Industry's Definition of Integrity

One of the challenges faced in any biopharmaceutical process is bioburden control and containment — or how do you keep what is out, "out" and what is in "in". For a stainless steel-based manufacturing...

Filtration and Biopharmaceutical Process Protection

Effective filtration is vital to process protection and factors such as filter selection, testing and optimization can have an impact on process risk. Here we examine the factors to consider when...

Protecting Your Bioprocess From the Risk of Human Error

In Parker Bioscience’s webinar entitled Protect The Process, Protect The Patient, the concern that biopharmaceutical manufacturers have regarding the impact of human error on their processes was all...
Comments

Have a question about Parker products or services? We can help: Contact Us!

Comments for How to Successfully Scale-Up Automated Single-Use Bioprocesses


Please note that, in an effort to combat spam, comments with hyperlinks will not be published.

Leave a comment





Captcha